Clinical trial
Cognitive Effects of Immunomodulatory Drugs in MS
NCT00229502 · Sharon Lynch, MD, Other · Completed
Key facts
| NCT number | NCT00229502 |
|---|---|
| Title | Cognitive Effects of Immunomodulatory Drugs in MS |
| Official title | Comparison of the Cognitive Effects of Three Immunomodulatory Drugs in Relapsing-Remitting Multiple Sclerosis: A Longitudinal Study |
| Lead sponsor | Sharon Lynch, MD, Other |
| Collaborators | EMD Serono Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Multiple Sclerosis |
| Enrollment | 96 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Sep 29, 2005 |
| Last update posted | Mar 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: